<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2006</study_start_year><condition>Colorectal Neoplasms</condition><condition>Cancer</condition><disease>Colorectal Neoplasms</disease><disease>Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2033345</full_dataset_link><location>United States</location><study_start_month>10</study_start_month><keyword>Advanced</keyword><keyword>Oxaliplatin</keyword><keyword>Colorectal</keyword><keyword>Metastatic</keyword><keyword>Leucovorin</keyword><keyword>Bevacizumab</keyword><keyword>Fluorouracil</keyword><keyword>Avastin</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer</name><description>To determine efficacy in the delivery of chronomodulated chemotherapy.</description><dates><creation>2006-10-15</creation></dates><accession>2033345</accession><cross_references><ClinicalTrials___gov>NCT00385021</ClinicalTrials___gov></cross_references></HashMap>